nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—ABCB1—ovarian cancer	0.299	1	CbGaD
Fentanyl—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0468	0.109	CbGbCtD
Fentanyl—CYP3A7—Paclitaxel—ovarian cancer	0.0468	0.109	CbGbCtD
Fentanyl—ABCB1—Topotecan—ovarian cancer	0.0462	0.107	CbGbCtD
Fentanyl—CYP3A5—Paclitaxel—ovarian cancer	0.0351	0.0816	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0339	0.0787	CbGbCtD
Fentanyl—CYP3A7—Docetaxel—ovarian cancer	0.0339	0.0787	CbGbCtD
Fentanyl—ABCB1—Vinorelbine—ovarian cancer	0.0325	0.0756	CbGbCtD
Fentanyl—CYP3A4—Topotecan—ovarian cancer	0.0277	0.0643	CbGbCtD
Fentanyl—CYP3A5—Docetaxel—ovarian cancer	0.0254	0.059	CbGbCtD
Fentanyl—ABCB1—Paclitaxel—ovarian cancer	0.0229	0.0531	CbGbCtD
Fentanyl—CYP3A4—Vinorelbine—ovarian cancer	0.0195	0.0453	CbGbCtD
Fentanyl—ABCB1—Docetaxel—ovarian cancer	0.0165	0.0384	CbGbCtD
Fentanyl—CYP3A4—Paclitaxel—ovarian cancer	0.0137	0.0318	CbGbCtD
Fentanyl—ABCB1—Doxorubicin—ovarian cancer	0.0123	0.0286	CbGbCtD
Fentanyl—CYP3A4—Docetaxel—ovarian cancer	0.0099	0.023	CbGbCtD
Fentanyl—CYP3A4—Doxorubicin—ovarian cancer	0.00738	0.0172	CbGbCtD
Fentanyl—Alfentanil—ABCB1—ovarian cancer	0.000205	0.265	CrCbGaD
Fentanyl—Astemizole—ABCB1—ovarian cancer	0.000159	0.206	CrCbGaD
Fentanyl—Fexofenadine—ABCB1—ovarian cancer	0.000114	0.147	CrCbGaD
Fentanyl—Propafenone—ABCB1—ovarian cancer	9.16e-05	0.118	CrCbGaD
Fentanyl—Hepatobiliary disease—Epirubicin—ovarian cancer	8.26e-05	0.000307	CcSEcCtD
Fentanyl—Anaphylactic shock—Docetaxel—ovarian cancer	8.26e-05	0.000307	CcSEcCtD
Fentanyl—Oedema—Docetaxel—ovarian cancer	8.26e-05	0.000307	CcSEcCtD
Fentanyl—Weight increased—Doxorubicin—ovarian cancer	8.25e-05	0.000306	CcSEcCtD
Fentanyl—Epistaxis—Epirubicin—ovarian cancer	8.24e-05	0.000306	CcSEcCtD
Fentanyl—Infection—Docetaxel—ovarian cancer	8.21e-05	0.000305	CcSEcCtD
Fentanyl—Weight decreased—Doxorubicin—ovarian cancer	8.2e-05	0.000305	CcSEcCtD
Fentanyl—Sinusitis—Epirubicin—ovarian cancer	8.2e-05	0.000304	CcSEcCtD
Fentanyl—Hyperglycaemia—Doxorubicin—ovarian cancer	8.18e-05	0.000304	CcSEcCtD
Fentanyl—Bepridil—ABCB1—ovarian cancer	8.16e-05	0.105	CrCbGaD
Fentanyl—Pneumonia—Doxorubicin—ovarian cancer	8.13e-05	0.000302	CcSEcCtD
Fentanyl—Shock—Docetaxel—ovarian cancer	8.13e-05	0.000302	CcSEcCtD
Fentanyl—Nervous system disorder—Docetaxel—ovarian cancer	8.1e-05	0.000301	CcSEcCtD
Fentanyl—Thrombocytopenia—Docetaxel—ovarian cancer	8.09e-05	0.0003	CcSEcCtD
Fentanyl—Infestation NOS—Doxorubicin—ovarian cancer	8.08e-05	0.0003	CcSEcCtD
Fentanyl—Drowsiness—Doxorubicin—ovarian cancer	8.08e-05	0.0003	CcSEcCtD
Fentanyl—Infestation—Doxorubicin—ovarian cancer	8.08e-05	0.0003	CcSEcCtD
Fentanyl—Tachycardia—Docetaxel—ovarian cancer	8.06e-05	0.000299	CcSEcCtD
Fentanyl—Feeling abnormal—Paclitaxel—ovarian cancer	8.03e-05	0.000298	CcSEcCtD
Fentanyl—Skin disorder—Docetaxel—ovarian cancer	8.02e-05	0.000298	CcSEcCtD
Fentanyl—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	8.02e-05	0.000298	CcSEcCtD
Fentanyl—Bradycardia—Epirubicin—ovarian cancer	7.98e-05	0.000297	CcSEcCtD
Fentanyl—Gastrointestinal pain—Paclitaxel—ovarian cancer	7.97e-05	0.000296	CcSEcCtD
Fentanyl—Renal failure—Doxorubicin—ovarian cancer	7.95e-05	0.000295	CcSEcCtD
Fentanyl—Neuropathy peripheral—Doxorubicin—ovarian cancer	7.92e-05	0.000294	CcSEcCtD
Fentanyl—Haemoglobin—Epirubicin—ovarian cancer	7.88e-05	0.000293	CcSEcCtD
Fentanyl—Stomatitis—Doxorubicin—ovarian cancer	7.88e-05	0.000293	CcSEcCtD
Fentanyl—Jaundice—Doxorubicin—ovarian cancer	7.88e-05	0.000293	CcSEcCtD
Fentanyl—Anorexia—Docetaxel—ovarian cancer	7.88e-05	0.000292	CcSEcCtD
Fentanyl—Rhinitis—Epirubicin—ovarian cancer	7.86e-05	0.000292	CcSEcCtD
Fentanyl—Urinary tract infection—Doxorubicin—ovarian cancer	7.86e-05	0.000292	CcSEcCtD
Fentanyl—Conjunctivitis—Doxorubicin—ovarian cancer	7.86e-05	0.000292	CcSEcCtD
Fentanyl—Haemorrhage—Epirubicin—ovarian cancer	7.84e-05	0.000291	CcSEcCtD
Fentanyl—Hypoaesthesia—Epirubicin—ovarian cancer	7.8e-05	0.00029	CcSEcCtD
Fentanyl—Pharyngitis—Epirubicin—ovarian cancer	7.78e-05	0.000289	CcSEcCtD
Fentanyl—Sweating—Doxorubicin—ovarian cancer	7.75e-05	0.000288	CcSEcCtD
Fentanyl—Urinary tract disorder—Epirubicin—ovarian cancer	7.75e-05	0.000288	CcSEcCtD
Fentanyl—Urticaria—Paclitaxel—ovarian cancer	7.74e-05	0.000288	CcSEcCtD
Fentanyl—Oedema peripheral—Epirubicin—ovarian cancer	7.73e-05	0.000287	CcSEcCtD
Fentanyl—Hypotension—Docetaxel—ovarian cancer	7.72e-05	0.000287	CcSEcCtD
Fentanyl—Haematuria—Doxorubicin—ovarian cancer	7.71e-05	0.000286	CcSEcCtD
Fentanyl—Connective tissue disorder—Epirubicin—ovarian cancer	7.71e-05	0.000286	CcSEcCtD
Fentanyl—Abdominal pain—Paclitaxel—ovarian cancer	7.71e-05	0.000286	CcSEcCtD
Fentanyl—Body temperature increased—Paclitaxel—ovarian cancer	7.71e-05	0.000286	CcSEcCtD
Fentanyl—Urethral disorder—Epirubicin—ovarian cancer	7.69e-05	0.000286	CcSEcCtD
Fentanyl—Hepatobiliary disease—Doxorubicin—ovarian cancer	7.65e-05	0.000284	CcSEcCtD
Fentanyl—Epistaxis—Doxorubicin—ovarian cancer	7.63e-05	0.000283	CcSEcCtD
Fentanyl—Sinusitis—Doxorubicin—ovarian cancer	7.58e-05	0.000282	CcSEcCtD
Fentanyl—Visual impairment—Epirubicin—ovarian cancer	7.56e-05	0.000281	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Docetaxel—ovarian cancer	7.53e-05	0.00028	CcSEcCtD
Fentanyl—Insomnia—Docetaxel—ovarian cancer	7.47e-05	0.000278	CcSEcCtD
Fentanyl—Paraesthesia—Docetaxel—ovarian cancer	7.42e-05	0.000276	CcSEcCtD
Fentanyl—Erythema multiforme—Epirubicin—ovarian cancer	7.42e-05	0.000275	CcSEcCtD
Fentanyl—Bradycardia—Doxorubicin—ovarian cancer	7.39e-05	0.000274	CcSEcCtD
Fentanyl—Dyspnoea—Docetaxel—ovarian cancer	7.37e-05	0.000274	CcSEcCtD
Fentanyl—Somnolence—Docetaxel—ovarian cancer	7.34e-05	0.000273	CcSEcCtD
Fentanyl—Eye disorder—Epirubicin—ovarian cancer	7.33e-05	0.000272	CcSEcCtD
Fentanyl—Tinnitus—Epirubicin—ovarian cancer	7.31e-05	0.000272	CcSEcCtD
Fentanyl—Haemoglobin—Doxorubicin—ovarian cancer	7.29e-05	0.000271	CcSEcCtD
Fentanyl—Cardiac disorder—Epirubicin—ovarian cancer	7.28e-05	0.00027	CcSEcCtD
Fentanyl—Flushing—Epirubicin—ovarian cancer	7.28e-05	0.00027	CcSEcCtD
Fentanyl—Rhinitis—Doxorubicin—ovarian cancer	7.28e-05	0.00027	CcSEcCtD
Fentanyl—Dyspepsia—Docetaxel—ovarian cancer	7.27e-05	0.00027	CcSEcCtD
Fentanyl—Haemorrhage—Doxorubicin—ovarian cancer	7.26e-05	0.00027	CcSEcCtD
Fentanyl—Loperamide—ABCB1—ovarian cancer	7.23e-05	0.0933	CrCbGaD
Fentanyl—Hypoaesthesia—Doxorubicin—ovarian cancer	7.22e-05	0.000268	CcSEcCtD
Fentanyl—Pharyngitis—Doxorubicin—ovarian cancer	7.2e-05	0.000268	CcSEcCtD
Fentanyl—Decreased appetite—Docetaxel—ovarian cancer	7.18e-05	0.000267	CcSEcCtD
Fentanyl—Hypersensitivity—Paclitaxel—ovarian cancer	7.18e-05	0.000267	CcSEcCtD
Fentanyl—Urinary tract disorder—Doxorubicin—ovarian cancer	7.17e-05	0.000266	CcSEcCtD
Fentanyl—Oedema peripheral—Doxorubicin—ovarian cancer	7.15e-05	0.000266	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Docetaxel—ovarian cancer	7.13e-05	0.000265	CcSEcCtD
Fentanyl—Connective tissue disorder—Doxorubicin—ovarian cancer	7.13e-05	0.000265	CcSEcCtD
Fentanyl—Fatigue—Docetaxel—ovarian cancer	7.12e-05	0.000265	CcSEcCtD
Fentanyl—Angiopathy—Epirubicin—ovarian cancer	7.12e-05	0.000264	CcSEcCtD
Fentanyl—Urethral disorder—Doxorubicin—ovarian cancer	7.11e-05	0.000264	CcSEcCtD
Fentanyl—Immune system disorder—Epirubicin—ovarian cancer	7.08e-05	0.000263	CcSEcCtD
Fentanyl—Mediastinal disorder—Epirubicin—ovarian cancer	7.07e-05	0.000263	CcSEcCtD
Fentanyl—Pain—Docetaxel—ovarian cancer	7.07e-05	0.000262	CcSEcCtD
Fentanyl—Constipation—Docetaxel—ovarian cancer	7.07e-05	0.000262	CcSEcCtD
Fentanyl—Chills—Epirubicin—ovarian cancer	7.04e-05	0.000261	CcSEcCtD
Fentanyl—Arrhythmia—Epirubicin—ovarian cancer	7.01e-05	0.00026	CcSEcCtD
Fentanyl—Visual impairment—Doxorubicin—ovarian cancer	6.99e-05	0.00026	CcSEcCtD
Fentanyl—Asthenia—Paclitaxel—ovarian cancer	6.99e-05	0.00026	CcSEcCtD
Fentanyl—Alopecia—Epirubicin—ovarian cancer	6.93e-05	0.000257	CcSEcCtD
Fentanyl—Pruritus—Paclitaxel—ovarian cancer	6.9e-05	0.000256	CcSEcCtD
Fentanyl—Mental disorder—Epirubicin—ovarian cancer	6.87e-05	0.000255	CcSEcCtD
Fentanyl—Erythema multiforme—Doxorubicin—ovarian cancer	6.86e-05	0.000255	CcSEcCtD
Fentanyl—Erythema—Epirubicin—ovarian cancer	6.83e-05	0.000254	CcSEcCtD
Fentanyl—Malnutrition—Epirubicin—ovarian cancer	6.83e-05	0.000254	CcSEcCtD
Fentanyl—Feeling abnormal—Docetaxel—ovarian cancer	6.81e-05	0.000253	CcSEcCtD
Fentanyl—Eye disorder—Doxorubicin—ovarian cancer	6.78e-05	0.000252	CcSEcCtD
Fentanyl—Tinnitus—Doxorubicin—ovarian cancer	6.77e-05	0.000251	CcSEcCtD
Fentanyl—Gastrointestinal pain—Docetaxel—ovarian cancer	6.76e-05	0.000251	CcSEcCtD
Fentanyl—Cardiac disorder—Doxorubicin—ovarian cancer	6.74e-05	0.00025	CcSEcCtD
Fentanyl—Flushing—Doxorubicin—ovarian cancer	6.74e-05	0.00025	CcSEcCtD
Fentanyl—Flatulence—Epirubicin—ovarian cancer	6.73e-05	0.00025	CcSEcCtD
Fentanyl—Tension—Epirubicin—ovarian cancer	6.7e-05	0.000249	CcSEcCtD
Fentanyl—Dysgeusia—Epirubicin—ovarian cancer	6.69e-05	0.000248	CcSEcCtD
Fentanyl—Diarrhoea—Paclitaxel—ovarian cancer	6.67e-05	0.000248	CcSEcCtD
Fentanyl—Nervousness—Epirubicin—ovarian cancer	6.63e-05	0.000246	CcSEcCtD
Fentanyl—Back pain—Epirubicin—ovarian cancer	6.6e-05	0.000245	CcSEcCtD
Fentanyl—Angiopathy—Doxorubicin—ovarian cancer	6.58e-05	0.000245	CcSEcCtD
Fentanyl—Muscle spasms—Epirubicin—ovarian cancer	6.56e-05	0.000244	CcSEcCtD
Fentanyl—Immune system disorder—Doxorubicin—ovarian cancer	6.56e-05	0.000243	CcSEcCtD
Fentanyl—Mediastinal disorder—Doxorubicin—ovarian cancer	6.54e-05	0.000243	CcSEcCtD
Fentanyl—Abdominal pain—Docetaxel—ovarian cancer	6.53e-05	0.000243	CcSEcCtD
Fentanyl—Body temperature increased—Docetaxel—ovarian cancer	6.53e-05	0.000243	CcSEcCtD
Fentanyl—Chills—Doxorubicin—ovarian cancer	6.51e-05	0.000242	CcSEcCtD
Fentanyl—Arrhythmia—Doxorubicin—ovarian cancer	6.48e-05	0.000241	CcSEcCtD
Fentanyl—Dizziness—Paclitaxel—ovarian cancer	6.45e-05	0.000239	CcSEcCtD
Fentanyl—Vision blurred—Epirubicin—ovarian cancer	6.43e-05	0.000239	CcSEcCtD
Fentanyl—Alopecia—Doxorubicin—ovarian cancer	6.41e-05	0.000238	CcSEcCtD
Fentanyl—Mental disorder—Doxorubicin—ovarian cancer	6.36e-05	0.000236	CcSEcCtD
Fentanyl—Ill-defined disorder—Epirubicin—ovarian cancer	6.34e-05	0.000235	CcSEcCtD
Fentanyl—Malnutrition—Doxorubicin—ovarian cancer	6.32e-05	0.000235	CcSEcCtD
Fentanyl—Erythema—Doxorubicin—ovarian cancer	6.32e-05	0.000235	CcSEcCtD
Fentanyl—Anaemia—Epirubicin—ovarian cancer	6.31e-05	0.000234	CcSEcCtD
Fentanyl—Agitation—Epirubicin—ovarian cancer	6.27e-05	0.000233	CcSEcCtD
Fentanyl—Flatulence—Doxorubicin—ovarian cancer	6.23e-05	0.000231	CcSEcCtD
Fentanyl—Tension—Doxorubicin—ovarian cancer	6.2e-05	0.00023	CcSEcCtD
Fentanyl—Vomiting—Paclitaxel—ovarian cancer	6.2e-05	0.00023	CcSEcCtD
Fentanyl—Dysgeusia—Doxorubicin—ovarian cancer	6.19e-05	0.00023	CcSEcCtD
Fentanyl—Malaise—Epirubicin—ovarian cancer	6.16e-05	0.000229	CcSEcCtD
Fentanyl—Rash—Paclitaxel—ovarian cancer	6.15e-05	0.000228	CcSEcCtD
Fentanyl—Dermatitis—Paclitaxel—ovarian cancer	6.14e-05	0.000228	CcSEcCtD
Fentanyl—Nervousness—Doxorubicin—ovarian cancer	6.14e-05	0.000228	CcSEcCtD
Fentanyl—Vertigo—Epirubicin—ovarian cancer	6.13e-05	0.000228	CcSEcCtD
Fentanyl—Syncope—Epirubicin—ovarian cancer	6.12e-05	0.000227	CcSEcCtD
Fentanyl—Leukopenia—Epirubicin—ovarian cancer	6.11e-05	0.000227	CcSEcCtD
Fentanyl—Back pain—Doxorubicin—ovarian cancer	6.11e-05	0.000227	CcSEcCtD
Fentanyl—Headache—Paclitaxel—ovarian cancer	6.11e-05	0.000227	CcSEcCtD
Fentanyl—Hypersensitivity—Docetaxel—ovarian cancer	6.09e-05	0.000226	CcSEcCtD
Fentanyl—Muscle spasms—Doxorubicin—ovarian cancer	6.07e-05	0.000226	CcSEcCtD
Fentanyl—Palpitations—Epirubicin—ovarian cancer	6.03e-05	0.000224	CcSEcCtD
Fentanyl—Loss of consciousness—Epirubicin—ovarian cancer	6e-05	0.000223	CcSEcCtD
Fentanyl—Cough—Epirubicin—ovarian cancer	5.96e-05	0.000221	CcSEcCtD
Fentanyl—Vision blurred—Doxorubicin—ovarian cancer	5.95e-05	0.000221	CcSEcCtD
Fentanyl—Asthenia—Docetaxel—ovarian cancer	5.93e-05	0.00022	CcSEcCtD
Fentanyl—Convulsion—Epirubicin—ovarian cancer	5.92e-05	0.00022	CcSEcCtD
Fentanyl—Hypertension—Epirubicin—ovarian cancer	5.9e-05	0.000219	CcSEcCtD
Fentanyl—Ill-defined disorder—Doxorubicin—ovarian cancer	5.86e-05	0.000218	CcSEcCtD
Fentanyl—Pruritus—Docetaxel—ovarian cancer	5.85e-05	0.000217	CcSEcCtD
Fentanyl—Anaemia—Doxorubicin—ovarian cancer	5.84e-05	0.000217	CcSEcCtD
Fentanyl—Myalgia—Epirubicin—ovarian cancer	5.81e-05	0.000216	CcSEcCtD
Fentanyl—Arthralgia—Epirubicin—ovarian cancer	5.81e-05	0.000216	CcSEcCtD
Fentanyl—Chest pain—Epirubicin—ovarian cancer	5.81e-05	0.000216	CcSEcCtD
Fentanyl—Agitation—Doxorubicin—ovarian cancer	5.81e-05	0.000216	CcSEcCtD
Fentanyl—Anxiety—Epirubicin—ovarian cancer	5.79e-05	0.000215	CcSEcCtD
Fentanyl—Nausea—Paclitaxel—ovarian cancer	5.79e-05	0.000215	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	5.77e-05	0.000214	CcSEcCtD
Fentanyl—Discomfort—Epirubicin—ovarian cancer	5.74e-05	0.000213	CcSEcCtD
Fentanyl—Malaise—Doxorubicin—ovarian cancer	5.7e-05	0.000212	CcSEcCtD
Fentanyl—Dry mouth—Epirubicin—ovarian cancer	5.69e-05	0.000211	CcSEcCtD
Fentanyl—Vertigo—Doxorubicin—ovarian cancer	5.68e-05	0.000211	CcSEcCtD
Fentanyl—Syncope—Doxorubicin—ovarian cancer	5.67e-05	0.00021	CcSEcCtD
Fentanyl—Leukopenia—Doxorubicin—ovarian cancer	5.66e-05	0.00021	CcSEcCtD
Fentanyl—Diarrhoea—Docetaxel—ovarian cancer	5.65e-05	0.00021	CcSEcCtD
Fentanyl—Confusional state—Epirubicin—ovarian cancer	5.62e-05	0.000209	CcSEcCtD
Fentanyl—Palpitations—Doxorubicin—ovarian cancer	5.58e-05	0.000207	CcSEcCtD
Fentanyl—Anaphylactic shock—Epirubicin—ovarian cancer	5.57e-05	0.000207	CcSEcCtD
Fentanyl—Oedema—Epirubicin—ovarian cancer	5.57e-05	0.000207	CcSEcCtD
Fentanyl—Loss of consciousness—Doxorubicin—ovarian cancer	5.55e-05	0.000206	CcSEcCtD
Fentanyl—Infection—Epirubicin—ovarian cancer	5.54e-05	0.000206	CcSEcCtD
Fentanyl—Cough—Doxorubicin—ovarian cancer	5.51e-05	0.000205	CcSEcCtD
Fentanyl—Shock—Epirubicin—ovarian cancer	5.48e-05	0.000204	CcSEcCtD
Fentanyl—Convulsion—Doxorubicin—ovarian cancer	5.47e-05	0.000203	CcSEcCtD
Fentanyl—Nervous system disorder—Epirubicin—ovarian cancer	5.46e-05	0.000203	CcSEcCtD
Fentanyl—Dizziness—Docetaxel—ovarian cancer	5.46e-05	0.000203	CcSEcCtD
Fentanyl—Thrombocytopenia—Epirubicin—ovarian cancer	5.46e-05	0.000203	CcSEcCtD
Fentanyl—Hypertension—Doxorubicin—ovarian cancer	5.45e-05	0.000203	CcSEcCtD
Fentanyl—Tachycardia—Epirubicin—ovarian cancer	5.44e-05	0.000202	CcSEcCtD
Fentanyl—Skin disorder—Epirubicin—ovarian cancer	5.41e-05	0.000201	CcSEcCtD
Fentanyl—Hyperhidrosis—Epirubicin—ovarian cancer	5.39e-05	0.0002	CcSEcCtD
Fentanyl—Arthralgia—Doxorubicin—ovarian cancer	5.38e-05	0.0002	CcSEcCtD
Fentanyl—Myalgia—Doxorubicin—ovarian cancer	5.38e-05	0.0002	CcSEcCtD
Fentanyl—Chest pain—Doxorubicin—ovarian cancer	5.38e-05	0.0002	CcSEcCtD
Fentanyl—Anxiety—Doxorubicin—ovarian cancer	5.36e-05	0.000199	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	5.34e-05	0.000198	CcSEcCtD
Fentanyl—Discomfort—Doxorubicin—ovarian cancer	5.31e-05	0.000197	CcSEcCtD
Fentanyl—Anorexia—Epirubicin—ovarian cancer	5.31e-05	0.000197	CcSEcCtD
Fentanyl—Dry mouth—Doxorubicin—ovarian cancer	5.26e-05	0.000195	CcSEcCtD
Fentanyl—Vomiting—Docetaxel—ovarian cancer	5.25e-05	0.000195	CcSEcCtD
Fentanyl—Rash—Docetaxel—ovarian cancer	5.21e-05	0.000193	CcSEcCtD
Fentanyl—Hypotension—Epirubicin—ovarian cancer	5.21e-05	0.000193	CcSEcCtD
Fentanyl—Dermatitis—Docetaxel—ovarian cancer	5.2e-05	0.000193	CcSEcCtD
Fentanyl—Confusional state—Doxorubicin—ovarian cancer	5.2e-05	0.000193	CcSEcCtD
Fentanyl—Headache—Docetaxel—ovarian cancer	5.18e-05	0.000192	CcSEcCtD
Fentanyl—Anaphylactic shock—Doxorubicin—ovarian cancer	5.16e-05	0.000192	CcSEcCtD
Fentanyl—Oedema—Doxorubicin—ovarian cancer	5.16e-05	0.000192	CcSEcCtD
Fentanyl—Methadone—ABCB1—ovarian cancer	5.15e-05	0.0664	CrCbGaD
Fentanyl—Infection—Doxorubicin—ovarian cancer	5.12e-05	0.00019	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Epirubicin—ovarian cancer	5.08e-05	0.000189	CcSEcCtD
Fentanyl—Shock—Doxorubicin—ovarian cancer	5.07e-05	0.000188	CcSEcCtD
Fentanyl—Nervous system disorder—Doxorubicin—ovarian cancer	5.06e-05	0.000188	CcSEcCtD
Fentanyl—Thrombocytopenia—Doxorubicin—ovarian cancer	5.05e-05	0.000188	CcSEcCtD
Fentanyl—Insomnia—Epirubicin—ovarian cancer	5.04e-05	0.000187	CcSEcCtD
Fentanyl—Tachycardia—Doxorubicin—ovarian cancer	5.03e-05	0.000187	CcSEcCtD
Fentanyl—Skin disorder—Doxorubicin—ovarian cancer	5.01e-05	0.000186	CcSEcCtD
Fentanyl—Paraesthesia—Epirubicin—ovarian cancer	5e-05	0.000186	CcSEcCtD
Fentanyl—Hyperhidrosis—Doxorubicin—ovarian cancer	4.98e-05	0.000185	CcSEcCtD
Fentanyl—Dyspnoea—Epirubicin—ovarian cancer	4.97e-05	0.000185	CcSEcCtD
Fentanyl—Somnolence—Epirubicin—ovarian cancer	4.95e-05	0.000184	CcSEcCtD
Fentanyl—Anorexia—Doxorubicin—ovarian cancer	4.91e-05	0.000183	CcSEcCtD
Fentanyl—Nausea—Docetaxel—ovarian cancer	4.91e-05	0.000182	CcSEcCtD
Fentanyl—Dyspepsia—Epirubicin—ovarian cancer	4.91e-05	0.000182	CcSEcCtD
Fentanyl—Decreased appetite—Epirubicin—ovarian cancer	4.84e-05	0.00018	CcSEcCtD
Fentanyl—Hypotension—Doxorubicin—ovarian cancer	4.82e-05	0.000179	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Epirubicin—ovarian cancer	4.81e-05	0.000179	CcSEcCtD
Fentanyl—Fatigue—Epirubicin—ovarian cancer	4.8e-05	0.000178	CcSEcCtD
Fentanyl—Pain—Epirubicin—ovarian cancer	4.77e-05	0.000177	CcSEcCtD
Fentanyl—Constipation—Epirubicin—ovarian cancer	4.77e-05	0.000177	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	4.7e-05	0.000174	CcSEcCtD
Fentanyl—Insomnia—Doxorubicin—ovarian cancer	4.66e-05	0.000173	CcSEcCtD
Fentanyl—Paraesthesia—Doxorubicin—ovarian cancer	4.63e-05	0.000172	CcSEcCtD
Fentanyl—Dyspnoea—Doxorubicin—ovarian cancer	4.6e-05	0.000171	CcSEcCtD
Fentanyl—Feeling abnormal—Epirubicin—ovarian cancer	4.59e-05	0.000171	CcSEcCtD
Fentanyl—Somnolence—Doxorubicin—ovarian cancer	4.58e-05	0.00017	CcSEcCtD
Fentanyl—Gastrointestinal pain—Epirubicin—ovarian cancer	4.56e-05	0.000169	CcSEcCtD
Fentanyl—Dyspepsia—Doxorubicin—ovarian cancer	4.54e-05	0.000169	CcSEcCtD
Fentanyl—Decreased appetite—Doxorubicin—ovarian cancer	4.48e-05	0.000166	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Doxorubicin—ovarian cancer	4.45e-05	0.000165	CcSEcCtD
Fentanyl—Fatigue—Doxorubicin—ovarian cancer	4.45e-05	0.000165	CcSEcCtD
Fentanyl—Urticaria—Epirubicin—ovarian cancer	4.43e-05	0.000164	CcSEcCtD
Fentanyl—Constipation—Doxorubicin—ovarian cancer	4.41e-05	0.000164	CcSEcCtD
Fentanyl—Pain—Doxorubicin—ovarian cancer	4.41e-05	0.000164	CcSEcCtD
Fentanyl—Abdominal pain—Epirubicin—ovarian cancer	4.41e-05	0.000164	CcSEcCtD
Fentanyl—Body temperature increased—Epirubicin—ovarian cancer	4.41e-05	0.000164	CcSEcCtD
Fentanyl—Feeling abnormal—Doxorubicin—ovarian cancer	4.25e-05	0.000158	CcSEcCtD
Fentanyl—Gastrointestinal pain—Doxorubicin—ovarian cancer	4.22e-05	0.000157	CcSEcCtD
Fentanyl—Hypersensitivity—Epirubicin—ovarian cancer	4.11e-05	0.000152	CcSEcCtD
Fentanyl—Urticaria—Doxorubicin—ovarian cancer	4.1e-05	0.000152	CcSEcCtD
Fentanyl—Abdominal pain—Doxorubicin—ovarian cancer	4.08e-05	0.000151	CcSEcCtD
Fentanyl—Body temperature increased—Doxorubicin—ovarian cancer	4.08e-05	0.000151	CcSEcCtD
Fentanyl—Asthenia—Epirubicin—ovarian cancer	4e-05	0.000148	CcSEcCtD
Fentanyl—Pruritus—Epirubicin—ovarian cancer	3.94e-05	0.000146	CcSEcCtD
Fentanyl—Diarrhoea—Epirubicin—ovarian cancer	3.81e-05	0.000142	CcSEcCtD
Fentanyl—Hypersensitivity—Doxorubicin—ovarian cancer	3.8e-05	0.000141	CcSEcCtD
Fentanyl—Asthenia—Doxorubicin—ovarian cancer	3.7e-05	0.000137	CcSEcCtD
Fentanyl—Dizziness—Epirubicin—ovarian cancer	3.69e-05	0.000137	CcSEcCtD
Fentanyl—Pruritus—Doxorubicin—ovarian cancer	3.65e-05	0.000135	CcSEcCtD
Fentanyl—Vomiting—Epirubicin—ovarian cancer	3.54e-05	0.000132	CcSEcCtD
Fentanyl—Diarrhoea—Doxorubicin—ovarian cancer	3.53e-05	0.000131	CcSEcCtD
Fentanyl—Rash—Epirubicin—ovarian cancer	3.51e-05	0.00013	CcSEcCtD
Fentanyl—Dermatitis—Epirubicin—ovarian cancer	3.51e-05	0.00013	CcSEcCtD
Fentanyl—Headache—Epirubicin—ovarian cancer	3.49e-05	0.00013	CcSEcCtD
Fentanyl—Dizziness—Doxorubicin—ovarian cancer	3.41e-05	0.000127	CcSEcCtD
Fentanyl—Nausea—Epirubicin—ovarian cancer	3.31e-05	0.000123	CcSEcCtD
Fentanyl—Vomiting—Doxorubicin—ovarian cancer	3.28e-05	0.000122	CcSEcCtD
Fentanyl—Rash—Doxorubicin—ovarian cancer	3.25e-05	0.000121	CcSEcCtD
Fentanyl—Dermatitis—Doxorubicin—ovarian cancer	3.25e-05	0.000121	CcSEcCtD
Fentanyl—Headache—Doxorubicin—ovarian cancer	3.23e-05	0.00012	CcSEcCtD
Fentanyl—Nausea—Doxorubicin—ovarian cancer	3.06e-05	0.000114	CcSEcCtD
